ROIVANT SCIENCES LTD.
ROIVCIK 0001635088
Revenue (TTM)
$14.76M
−71.6% YoY
FY May 2026
Net Income (TTM)
−$433.38M
−74.3% YoY
FY May 2026
EPS Diluted (TTM)
−$0.65
−125.0% YoY
FY May 2026
Gross Margin
—
FY May 2026
Operating Margin
-8,163.0%
FY May 2026
Net Margin
-2,936.6%
FY May 2026
Free Cash Flow (TTM)
−$912.09M
FY May 2026
Cash
$1.42B
FY May 2026
Total Debt
$243.33M
FY May 2026
Shares Outstanding
719.27M sh
FY May 2026